Picture of Climb Bio logo

CLYM — Climb Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Eliem Therapeutics Reports Second Quarter Financial Results

Sept 13 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS REPORTS SECOND QUARTER FINANCIAL
RESULTS
    * ELIEM THERAPEUTICS - QTRLY LOSS PER SHARE $3.11
    * ELIEM THERAPEUTICS INC - CASH WAS $99.5 MILLION AS OF JUNE
30,
2021

Source text for Eikon:  ID:nGNX3DYd6B 
Further company coverage:  ELYM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Climb Bio

See all news